Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Chromatin Licensing and DNA Replication Factor 1 (CDT1) Peptid

CDT1 Wirt: Synthetic BP, IHC, WB
Produktnummer ABIN8096999
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Chromatin Licensing and DNA Replication Factor 1 (CDT1) Peptid (ABIN8096999)

Target

CDT1 (Chromatin Licensing and DNA Replication Factor 1 (CDT1))

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
  • Verwendungszweck

    CDT1 Peptide
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti-CDT1 antibody ( ARP46350_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    CDT1 (Chromatin Licensing and DNA Replication Factor 1 (CDT1))

    Hintergrund

    Background Information: CDT1 cooperates with CDC6 to promote the loading of the mini-chromosome maintenance complex onto chromatin to form the pre-replication complex necessary to initiate DNA replication. It binds DNA in a sequence-, strand-, and conformation-independent manner and is a potential oncogene.

    Alternative Symbols: DUP, RIS2

    Molekulargewicht

    60kDa

    Gen-ID

    81620

    NCBI Accession

    NP_112190

    UniProt

    Q9H211
Sie sind hier:
Chat with us!